Gene · 2296
Papers3,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune-related biomarkers shared by inflammatory bowel disease and liver cancer. | PLoS One | 2022 | 35452485 | PubTator, text mining | PubMed |
| Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. | Front Pharmacol | 2022 | 35444536 | PubTator, text mining | PubMed |
| Evaluating adipose-derived stem cell exosomes as miRNA drug delivery systems for the treatment of bladder cancer. | Cancer Med | 2022 | 35441482 | PubTator, text mining | PubMed |
| Intellectual disability associated with craniofacial dysmorphism due to POLR3B mutation and defect in spliceosomal machinery. | BMC Med Genomics | 2022 | 35436926 | PubTator, text mining | PubMed |
TXNRD2 (rs35934224) CT genotype and primary open-angle glaucoma: correspondenceReply to "TXNRD2 (rs35934224) CT genotype and primary open-angle glaucoma: correspondence"Primary open-angle glaucomaGenome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucomaGenome-wide association study of primary open-angle glaucoma in continental and admixed African populations. | Arq Bras Oftalmol | 2022 | 35416905 | PubTator, text mining | PubMed |
| Integrative analyses of hub genes and their association with immune infiltration in adipose tissue, liver tissue and skeletal muscle of obese patients after bariatric surgery. | Adipocyte | 2022 | 35412419 | PubTator, text mining | PubMed |
| Metastasis and MAPK Pathways. | Int J Mol Sci | 2022 | 35409206 | PubTator, text mining | PubMed |
| The Role of mTOR and eIF Signaling in Benign Endometrial Diseases. | Int J Mol Sci | 2022 | 35408777 | PubTator, text mining | PubMed |
| Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem. | Cancers (Basel) | 2022 | 35406495 | PubTator, text mining | PubMed |
| FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer. | Cancers (Basel) | 2022 | 35406487 | PubTator, text mining | PubMed |
| Neuronal miR-138 Represses HSV-2 Lytic Infection by Regulating Viral and Host Genes with Mechanistic Differences from HSV-1. | J Virol | 2022 | 35404085 | PubTator, text mining | PubMed |
| Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches. | PLoS One | 2022 | 35390032 | PubTator, text mining | PubMed |
| Endogenous ROS production in early differentiation state suppresses endoderm differentiation via transient FOXC1 expression. | Cell Death Discov | 2022 | 35365611 | PubTator, text mining | PubMed |
| Comparison of Anterior Segment Abnormalities in Individuals With FOXC1 and PITX2 Variants. | Cornea | 2022 | 35354164 | PubTator, text mining | PubMed |
| FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway. | J Clin Invest | 2022 | 35349489 | PubTator, text mining | PubMed |
| RNA Sequencing of Lens Capsular Epithelium Implicates Novel Pathways in Pseudoexfoliation Syndrome. | Invest Ophthalmol Vis Sci | 2022 | 35348588 | PubTator, text mining | PubMed |
| Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis. | J Pathol | 2022 | 35342947 | PubTator, text mining | PubMed |
| Pan-cancer predictions of transcription factors mediating aberrant DNA methylation. | Epigenetics Chromatin | 2022 | 35331302 | PubTator, text mining | PubMed |
| Variable Anterior Segment Dysgenesis and Cardiac Anomalies Caused by a Novel Truncating Variant of FOXC1. | Genes (Basel) | 2022 | 35327965 | PubTator, text mining | PubMed |
| Stroke Genomics: Current Knowledge, Clinical Applications and Future Possibilities. | Brain Sci | 2022 | 35326259 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2296/papers?page=44